Basic Information
Proximagen is a publicly traded neuroscience research company focused on drug development for neurodegenerative diseases, including Parkinson's disease and Alzheimer's disease.
Proximagen
London,England,United Kingdom
15~50 people
January 01, 2003
info@proximagen.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios